148 related articles for article (PubMed ID: 8252763)
1. Phototoxic eruptions due to doxycycline--a dose-related phenomenon.
Layton AM; Cunliffe WJ
Clin Exp Dermatol; 1993 Sep; 18(5):425-7. PubMed ID: 8252763
[TBL] [Abstract][Full Text] [Related]
2. The "Heart Sign": An Early Indicator of Dose-Dependent Doxycycline-Induced Phototoxicity.
Nguyen TA; Krakowski AC
Pediatr Dermatol; 2016; 33(2):e69-71. PubMed ID: 26764127
[TBL] [Abstract][Full Text] [Related]
3. Tetracycline/doxycycline-induced cutaneous depressed pigmentation.
Adişen E; Gürer MA; Erdem O
Int J Dermatol; 2006 Oct; 45(10):1245-7. PubMed ID: 17040455
[No Abstract] [Full Text] [Related]
4. [Treatment of acne vulgaris. A comparison of doxycycline versus minocycline].
Laux B
Hautarzt; 1989 Sep; 40(9):577-81. PubMed ID: 2530191
[TBL] [Abstract][Full Text] [Related]
5. Red in the face.
Hafiji J; Batchelor J
BMJ; 2010 Jan; 340():b5643. PubMed ID: 20106883
[No Abstract] [Full Text] [Related]
6. [Doxycycline].
Bonnetblanc JM
Ann Dermatol Venereol; 2002; 129(6-7):874-82. PubMed ID: 12218915
[TBL] [Abstract][Full Text] [Related]
7. High protective effect of a broad-spectrum sunscreen against tetracycline phototoxicity.
Duteil I; Queille-Roussel C; Rougier A; Richard A; Ortonne JP
Eur J Dermatol; 2002; 12(4):X-XI. PubMed ID: 12118428
[No Abstract] [Full Text] [Related]
8. Doxycycline-induced cutaneous inflammation with systemic symptoms in a patient with acne vulgaris.
Weinstein M; Laxer R; Debosz J; Somers G
J Cutan Med Surg; 2013; 17(4):283-6. PubMed ID: 23815962
[TBL] [Abstract][Full Text] [Related]
9. Photosensitivity due to doxycycline hydrochloride with an unusual flare.
Tanaka N; Kawada A; Ohnishi Y; Hiruma M; Tajima S; Akiyama M; Ishibashi A
Contact Dermatitis; 1997 Aug; 37(2):93-4. PubMed ID: 9285175
[No Abstract] [Full Text] [Related]
10. Lichenoid photosensitivity: an unusual reaction to doxycycline and an unusual response.
Susong J; Carrizales S
Cutis; 2014 May; 93(5):E1-2. PubMed ID: 24897144
[No Abstract] [Full Text] [Related]
11. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne.
Toossi P; Farshchian M; Malekzad F; Mohtasham N; Kimyai-Asadi A
J Drugs Dermatol; 2008 Dec; 7(12):1149-52. PubMed ID: 19137768
[TBL] [Abstract][Full Text] [Related]
12. A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium.
Leyden JJ; Bruce S; Lee CS; Ling M; Sheth PB; Stewart DM; Werschler WP; Gilbert RD; Kircik L
J Drugs Dermatol; 2013 Jun; 12(6):658-63. PubMed ID: 23839182
[TBL] [Abstract][Full Text] [Related]
13. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease.
Margolis DJ; Fanelli M; Hoffstad O; Lewis JD
Am J Gastroenterol; 2010 Dec; 105(12):2610-6. PubMed ID: 20700115
[TBL] [Abstract][Full Text] [Related]
14. Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: What is the role of age?
Babaeinejad S; Khodaeiani E; Fouladi RF
J Dermatolog Treat; 2011 Aug; 22(4):206-10. PubMed ID: 20666686
[TBL] [Abstract][Full Text] [Related]
15. Systemic antibiotic therapy of acne vulgaris.
Ochsendorf F
J Dtsch Dermatol Ges; 2006 Oct; 4(10):828-41. PubMed ID: 17010172
[TBL] [Abstract][Full Text] [Related]
16. Lack of cross-sensitivity between tetracycline, doxycycline, and minocycline with regard to fixed drug sensitivity to tetracycline.
Bargman H
J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):900-2. PubMed ID: 6239882
[No Abstract] [Full Text] [Related]
17. Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline.
Eady EA; Jones CE; Gardner KJ; Taylor JP; Cove JH; Cunliffe WJ
Br J Dermatol; 1993 May; 128(5):556-60. PubMed ID: 8504049
[TBL] [Abstract][Full Text] [Related]
18. Fewer adverse effects with doxycycline than with minocycline.
Prescrire Int; 2009 Oct; 18(103):213. PubMed ID: 19882792
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications.
Kircik LH
J Drugs Dermatol; 2010 Nov; 9(11):1407-11. PubMed ID: 21061764
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
